Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: Post-hoc analysis from MagnetisMM-3 Meeting Abstract
| Authors: | Leleu, X.; Bahlis, N.; Rodríguez-Otero, P.; Quach, H.; Touzeau, C.; Depaus, J.; Iida, S.; Hänel, M.; Wrobel, T.; Leip, E.; Conte, U.; Sullivan, S.; Viqueira, A.; Lesokhin, A. |
| Abstract Title: | Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: Post-hoc analysis from MagnetisMM-3 |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S194 |
| Language: | English |
| ACCESSION: | WOS:001079705400338 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01904-3 |
| Notes: | Meeting Abstract: P-286 -- Source: Wos |
